feed,title,long_url,short_url
Benzinga,"Axsome Therapeutics Clocks Better Than Expected Q1 Sales, Depression Drug Sees Improved Coverage",https://benzinga.com/analyst-ratings/analyst-color/23/05/32269069/axsome-therapeutics-clocks-better-than-expected-q1-sales-depression-drug-sees-impro,https://da.gd/XsUr
Benzinga,Eyenovia Shares Dip Despite FDA Approving Its First Product,https://benzinga.com/general/biotech/23/05/32266254/eyenovia-shares-dip-despite-fda-approving-its-first-product,https://da.gd/8RzdK8
